← Back to front page
Asia · General news · New Straits Times

Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil

Published by New Straits Times · Malaysia 8 h ago

Detailed summary

Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people…

Read the full article on New Straits Times Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nst.com.my)

Also worth reading